How is IV to SC Evolving?

Session details:

The shift from intravenous (IV) to subcutaneous (SC) delivery is reshaping patient experience, healthcare efficiency and commercial strategy. This panel will examine the latest innovations enabling this transition – from high-volume formulations and advanced delivery devices to new technologies that support faster, more convenient administration. Panelists will address how companies are overcoming formulation and engineering challenges, navigating regulatory pathways, and delivering value through improved access, reduced healthcare burden, and enhanced patient preference.